GYRE - Gyre Therapeutics Inc
IEX Last Trade
13.385
-0.345 -2.578%
Share volume: 32,987
Last Updated: Fri 30 Aug 2024 07:58:15 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$13.73
-0.35
-2.51%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-15 | 2022-11-14 | 2023-03-30 | 2023-05-15 | 2023-08-14 | 2023-10-26 | 2024-03-27 | 2024-05-13 | |
Cash flow financing | 0.000 | -45.027 M | 0.000 | -7.762 M | -3.500 M | -1.478 M | 15.240 M | 658.000 K | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | -12.294 M | -7.277 M | -1.475 M | -6.216 M | -2.471 M | -3.217 M | 37.796 M | 2.884 M | |
Net income | 51.632 M | -4.884 M | -40.454 M | 260.000 K | -2.472 M | -1.576 M | -89.145 M | 7.532 M | |
Depreciation | 67.000 K | 40.000 K | 10.000 K | 3.000 K | 1.000 K | 0.000 | 1.070 M | 415.000 K | |
Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 4.281 M | 4.939 M | |
Changes in receivables | 5.000 M | 5.000 M | 5.000 M | 5.000 M | 0.000 | 1.200 M | 16.839 M | 16.745 M | |
Investing Cashflow | 52.871 M | 0.000 | 51.000 K | 411.000 K | 4.795 M | 0.000 | -24.966 M | -7.220 M | |
Net Borrowings | -76.308 M | -25.246 M | -23.206 M | -9.014 M | -7.620 M | -3.932 M | -36.101 M | -41.039 M | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -8.586 M | -231.000 K | |
Cash Change | 75.394 M | 23.090 M | 21.666 M | 8.099 M | 6.923 M | 2.228 M | 33.509 M | 29.785 M |